160 related articles for article (PubMed ID: 36931700)
81. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2.
Min SH; Kim DM; Heo YS; Kim HM; Kim IC; Yoo OJ
Life Sci; 2010 Jan; 86(1-2):66-72. PubMed ID: 19945467
[TBL] [Abstract][Full Text] [Related]
82. Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway.
Liang Y; Hou L; Li L; Li L; Zhu L; Wang Y; Huang X; Hou Y; Zhu D; Zou H; Gu Y; Weng X; Wang Y; Li Y; Wu T; Yao M; Gross I; Gaiddon C; Luo M; Wang J; Meng X
Oncogene; 2020 Jan; 39(2):469-485. PubMed ID: 31597953
[TBL] [Abstract][Full Text] [Related]
83. Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells.
Putri HE; Nutho B; Rungrotmongkol T; Sritularak B; Vinayanuwattikun C; Chanvorachote P
Phytomedicine; 2021 May; 85():153534. PubMed ID: 33773191
[TBL] [Abstract][Full Text] [Related]
84. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
[TBL] [Abstract][Full Text] [Related]
85. Ajuba functions as a histone deacetylase-dependent co-repressor for autoregulation of the growth factor-independent-1 transcription factor.
Montoya-Durango DE; Velu CS; Kazanjian A; Rojas ME; Jay CM; Longmore GD; Grimes HL
J Biol Chem; 2008 Nov; 283(46):32056-65. PubMed ID: 18805794
[TBL] [Abstract][Full Text] [Related]
86. MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
Kwak B; Kim DU; Kim TO; Kim HS; Kim SW
Int J Oncol; 2018 Oct; 53(4):1800-1808. PubMed ID: 30066856
[TBL] [Abstract][Full Text] [Related]
87. P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation.
Li XL; Zhou J; Chen ZR; Chng WJ
World J Gastroenterol; 2015 Jan; 21(1):84-93. PubMed ID: 25574081
[TBL] [Abstract][Full Text] [Related]
88. Ajuba family proteins link JNK to Hippo signaling.
Sun G; Irvine KD
Sci Signal; 2013 Sep; 6(292):ra81. PubMed ID: 24023255
[TBL] [Abstract][Full Text] [Related]
89. TGFβ1I1 suppressed cell migration and invasion in colorectal cancer by inhibiting the TGF-β pathway and EMT progress.
Ruan XJ; Ye BL; Zheng ZH; Li ST; Zheng XF; Zhang SZ
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7294-7302. PubMed ID: 32706067
[TBL] [Abstract][Full Text] [Related]
90. TRPV1 Induced Apoptosis of Colorectal Cancer Cells by Activating Calcineurin-NFAT2-p53 Signaling Pathway.
Hou N; He X; Yang Y; Fu J; Zhang W; Guo Z; Hu Y; Liang L; Xie W; Xiong H; Wang K; Pang M
Biomed Res Int; 2019; 2019():6712536. PubMed ID: 31183372
[TBL] [Abstract][Full Text] [Related]
91. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
[TBL] [Abstract][Full Text] [Related]
92. Expression of circZNF609 is Down-Regulated in Colorectal Cancer Tissue and Promotes Apoptosis in Colorectal Cancer Cells by Upregulating p53.
Zhang X; Zhao Y; Kong P; Han M; Li B
Med Sci Monit; 2019 Aug; 25():5977-5985. PubMed ID: 31401644
[TBL] [Abstract][Full Text] [Related]
93. FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX.
Ling X; Xu C; Fan C; Zhong K; Li F; Wang X
Cancer Res; 2014 Dec; 74(24):7487-97. PubMed ID: 25512388
[TBL] [Abstract][Full Text] [Related]
94. Long Non-Coding RNA (lncRNA) BMP/OP-Responsive Gene (BORG) Promotes Development of Chemoresistance of Colorectal Cancer Cells to Carboplatin.
Li J; Ma J; Zhang X; Tai X; Liu L; Zhang L
Med Sci Monit; 2020 Jan; 26():e919103. PubMed ID: 31937750
[TBL] [Abstract][Full Text] [Related]
95. PMN inhibits colorectal cancer cells through inducing mitotic arrest and p53-dependent apoptosis via the inhibition of tubulin polymerization.
Wu X; Shen Y
Biochem Biophys Res Commun; 2018 May; 499(4):927-933. PubMed ID: 29626471
[TBL] [Abstract][Full Text] [Related]
96. The scaffold protein Ajuba suppresses CdGAP activity in epithelia to maintain stable cell-cell contacts.
McCormack JJ; Bruche S; Ouadda ABD; Ishii H; Lu H; Garcia-Cattaneo A; Chávez-Olórtegui C; Lamarche-Vane N; Braga VMM
Sci Rep; 2017 Aug; 7(1):9249. PubMed ID: 28835688
[TBL] [Abstract][Full Text] [Related]
97. Ajuba, a novel LIM protein, interacts with Grb2, augments mitogen-activated protein kinase activity in fibroblasts, and promotes meiotic maturation of Xenopus oocytes in a Grb2- and Ras-dependent manner.
Goyal RK; Lin P; Kanungo J; Payne AS; Muslin AJ; Longmore GD
Mol Cell Biol; 1999 Jun; 19(6):4379-89. PubMed ID: 10330178
[TBL] [Abstract][Full Text] [Related]
98. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
[TBL] [Abstract][Full Text] [Related]
99. Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma.
Peng L; Jiang Y; Chen H; Wang Y; Lan Q; Chen S; Huang Z; Zhang J; Tian D; Qiu Y; Cai D; Peng J; Lu D; Yuan X; Yang X; Yin D
Acta Pharm Sin B; 2024 May; 14(5):2119-2136. PubMed ID: 38799645
[TBL] [Abstract][Full Text] [Related]
100. A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells.
Sohail M; Shkreta L; Toutant J; Rabea S; Babeu JP; Huard C; Coulombe-Huntington J; Delannoy A; Placet M; Geha S; Gendron FP; Boudreau F; Tyers M; Grierson DS; Chabot B
NAR Cancer; 2021 Jun; 3(2):zcab019. PubMed ID: 34316707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
